132 related articles for article (PubMed ID: 1664810)
1. Ki-67 immunostaining and survival in operable lung cancer.
Tungekar MF; Gatter KC; Dunnill MS; Mason DY
Histopathology; 1991 Dec; 19(6):545-50. PubMed ID: 1664810
[TBL] [Abstract][Full Text] [Related]
2. Predicting prognosis in lung cancer: use of proliferation marker, Ki67 monoclonal antibody.
Soomro IN; Holmes J; Whimster WF
J Pak Med Assoc; 1998 Mar; 48(3):66-9. PubMed ID: 9783030
[TBL] [Abstract][Full Text] [Related]
3. New approach to assessing lung tumours in man.
Gatter KC; Dunnill MS; Gerdes J; Stein H; Mason DY
J Clin Pathol; 1986 Jun; 39(6):590-3. PubMed ID: 3013945
[TBL] [Abstract][Full Text] [Related]
4. [Surgical indication based on prognostic factors in pT1 tumors of the lung].
Komatsu H; Katayama T; Murakami K; Sagara Y; Hayashi K
Kyobu Geka; 1991 Jan; 44(1):61-4. PubMed ID: 1645422
[TBL] [Abstract][Full Text] [Related]
5. An assessment of MAC 387 antibody as a diagnostically useful marker of L1 epithelial antigen expression by lung tumours.
Mayall FG; Gibbs AR
J Pathol; 1991 May; 164(1):47-50. PubMed ID: 1647450
[TBL] [Abstract][Full Text] [Related]
6. [The postoperative survival in pulmonary carcinomas depending on the histological type and stage].
Campobasso O; Andrion A; Mancuso M; De Simone M; Ribotta M
Ann Osp Maria Vittoria Torino; 1989-1990; 31():9-24. PubMed ID: 2562416
[TBL] [Abstract][Full Text] [Related]
7. Proliferating cell nuclear antigen and Ki-67 in lung carcinoma. Correlation with DNA flow cytometric analysis.
Kawai T; Suzuki M; Kono S; Shinomiya N; Rokutanda M; Takagi K; Ogata T; Tamai S
Cancer; 1994 Nov; 74(9):2468-75. PubMed ID: 7923002
[TBL] [Abstract][Full Text] [Related]
8. Prognosis of early bronchogenic carcinoma. Survival curves of 451 patients after resection of lung cancer in relation to the results of pre-operative tuberculin skin test.
Israel L; Mugica J; Chahinian P
Biomedicine; 1973 Feb; 19(2):68-72. PubMed ID: 4354467
[No Abstract] [Full Text] [Related]
9. Comparison of proliferation rates assessed using "multiblock" and conventional tissue blocks of lung carcinoma.
Brown DC; Gatter KC
J Clin Pathol; 1992 Jul; 45(7):579-82. PubMed ID: 1355493
[TBL] [Abstract][Full Text] [Related]
10. [The surgical therapy of stage-III pulmonary cancer. Comments on 71 cases].
Briccoli A; Beghi M; Farinetti A; Guernelli N
Minerva Med; 1989 Jul; 80(7):677-8. PubMed ID: 2550849
[No Abstract] [Full Text] [Related]
11. Ki-67 expression and prognosis for smokers with resected stage I non-small cell lung cancer.
Haga Y; Hiroshima K; Iyoda A; Shibuya K; Shimamura F; Iizasa T; Fujisawa T; Ohwada H
Ann Thorac Surg; 2003 Jun; 75(6):1727-32; discussion 1732-3. PubMed ID: 12822607
[TBL] [Abstract][Full Text] [Related]
12. The frequency of neuroendocrine cell hyperplasia in patients with pulmonary neuroendocrine tumours and non-neuroendocrine cell carcinomas.
Rizvi SM; Goodwill J; Lim E; Yap YK; Wells AU; Hansell DM; Davis P; Selim AG; Goldstraw P; Nicholson AG
Histopathology; 2009 Sep; 55(3):332-7. PubMed ID: 19723148
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of MIB-1 in neuroendocrine tumours of the lung.
Böhm J; Koch S; Gais P; Jütting U; Präuer HW; Höfler H
J Pathol; 1996 Apr; 178(4):402-9. PubMed ID: 8691318
[TBL] [Abstract][Full Text] [Related]
14. Langerhans cells in human lung tumours: an immunohistological study.
Fox SB; Jones M; Dunnill MS; Gatter KC; Mason DY
Histopathology; 1989 Mar; 14(3):269-75. PubMed ID: 2707762
[TBL] [Abstract][Full Text] [Related]
15. An immunohistochemical study of lung carcinomas using a monoclonal antibody which specifically reacts to basal cells.
Maeda K; Sueishi K
Mod Pathol; 1990 Jan; 3(1):43-8. PubMed ID: 2155419
[TBL] [Abstract][Full Text] [Related]
16. Carcinoma of the cervix uteri: an assessment of the relationship of tumour proliferation to prognosis.
Cole DJ; Brown DC; Crossley E; Alcock CJ; Gatter KC
Br J Cancer; 1992 May; 65(5):783-5. PubMed ID: 1586610
[TBL] [Abstract][Full Text] [Related]
17. Surgery for combined type small cell lung carcinoma.
Hage R; Elbers JR; Brutel de la Rivière A; van den Bosch JM
Thorax; 1998 Jun; 53(6):450-3. PubMed ID: 9713442
[TBL] [Abstract][Full Text] [Related]
18. The relationship of p53 immunostaining to survival in carcinoma of the lung.
McLaren R; Kuzu I; Dunnill M; Harris A; Lane D; Gatter KC
Br J Cancer; 1992 Oct; 66(4):735-8. PubMed ID: 1329907
[TBL] [Abstract][Full Text] [Related]
19. MCM2 is an independent predictor of survival in patients with non-small-cell lung cancer.
Ramnath N; Hernandez FJ; Tan DF; Huberman JA; Natarajan N; Beck AF; Hyland A; Todorov IT; Brooks JS; Bepler G
J Clin Oncol; 2001 Nov; 19(22):4259-66. PubMed ID: 11709570
[TBL] [Abstract][Full Text] [Related]
20. Lung cancer in the young.
Roviaro GC; Varoli F; Zannini P; Fascianella A; Pezzuoli G
Chest; 1985 Apr; 87(4):456-9. PubMed ID: 2983952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
